| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |